Opportunity ID: 334775
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-21-267 |
Funding Opportunity Title: | NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jul 16, 2021 |
Last Updated Date: | Nov 27, 2023 |
Original Closing Date for Applications: | Apr 05, 2024 |
Current Closing Date for Applications: | Nov 26, 2023 |
Archive Date: | Dec 26, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: |
(Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-267.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
expired and re-issued as PAR-24-044 | Nov 27, 2023 | |
Jul 16, 2021 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-21-267 |
Funding Opportunity Title: | NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jul 16, 2021 |
Last Updated Date: | Nov 27, 2023 |
Original Closing Date for Applications: | Apr 05, 2024 |
Current Closing Date for Applications: | Nov 26, 2023 |
Archive Date: | Dec 26, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: |
(Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-267.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-21-267 |
Funding Opportunity Title: | NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jul 16, 2021 |
Last Updated Date: | Jul 16, 2021 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Apr 05, 2024 |
Archive Date: | May 11, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | (Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-267.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Related Documents
Packages
Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268217 | Aug 07, 2021 | Jan 24, 2022 | View | |
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270952 | Dec 16, 2021 | Jan 24, 2023 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278358 | Nov 14, 2022 | Nov 28, 2023 | View |